Skin directed therapies alone or in combination are the primary treatment options for stage IA and IIA MF. Choice of therapy is made based on physician experience, patient characteristics and side effect profiles. Skin directed therapies include:

  • Topical corticosteroids
  • Topical chemotherapy (mechlorethamine [nitrogen mustard], carmustine)
  • Local radiation (for limited/localized skin involvement)
  • Phototherapy (UVB, nbUVB for patch/thin plaques; PUVA for thicker plaques)
  • Topical retinoids
  • Total electron beam therapy (reserved for those with severe skin symptoms or generalized thick plaque or tumor disease, or poor response to other therapies)

NCCN Guidelines Version 3.2011

 

US RESIDENTS

Please note that the information contained in this section of the website is not intended for US residents. Please visit our US webpage.

Please note that the information contained in this section of the website is not intended for US residents. Please visit our US webpage.

Related Links